SCHEMBL13460366

SCHEMBL13460366

NCOCC1C=CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384212 0.78 SMN1; SMN2 (0.31)
SCHEMBL27701215 0.78
SCHEMBL1149443 0.75
SCHEMBL23809026 0.75
SCHEMBL13460364 0.75
SCHEMBL15889041 0.75
SCHEMBL9885497 0.74
SCHEMBL1914163 0.74
SCHEMBL14074643 0.74
SCHEMBL19937500 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683164-B2 Nucleic acid derivatives BIO-RAD LABORATORIES INC. (US) 2010-03-23 US disclosed
US-20090005334-A1 cyclic moieties which enable the formation of stable hybrids with natural nucleic acids and can therefore be efficiently used in a wide variety of applications and, in particular, in antisense therapy BIO-RAD LABORATORIES INC. (US) 2009-01-01 US disclosed